Anti-CD160, Alone or in Combination With Bevacizumab, Is a Potent Inhibitor of Ocular Neovascularization in Rabbit and Monkey ModelsThierry Menguy, Philippe Le Bouteiller|Investigative Ophthalmology & Visual Science|2018Cited by 10